GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the first quarter ended March 31, 2023. GE HealthCare President and CEO Peter Arduini said, “We saw strong revenue growth across all of our business…
Veristat, a scientific-minded, global clinical research organization (CRO), today congratulated HIPRA for marketing authorization by the European Medicines Agency (EMA) and European Commission of BIMERVAX®, a bivalent adjuvanted vaccine based on the Beta and Alpha variants of SARS-CoV-2 and indicated as a booster…
FineHeart S.A, a medical device company developing the FLOWMAKER®, a fully implantable cardiac output restoration system (ICOMS) to address the unmet needs of patients suffering from severe heart failure, announced today that its first two patents have been granted in…
Oftentimes, women are the caretakers and CEOs of their families’ health needs, but sometimes that comes at a cost to their own well-being. According to the National Institute of Health, women make nearly 80% of the health care decisions for their families.…
Abbott (NYSE: ABT) today announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations. The new additions to Abbott’s Diversity in Clinical Trials initiative build on the partnerships,…
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling for its Eterna™ spinal cord stimulation (SCS) system to include new leads that are MR conditional, which means people with chronic pain can undergo…
Stop what you’re doing for a moment and listen to your body. Is it telling you anything? Are you hungry? How’s your mood? The point being, it’s hard to know exactly what’s going on in there, even if you think…
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2023. First-quarter 2023 net sales were $676.8 million, a decrease of…
The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the first quarter…
The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it…
Global health company The Cigna Group (NYSE: CI) today reported strong first quarter 2023 results reflecting growth and focused execution across our diversified portfolio of businesses. “Our strong results in the first quarter demonstrate how our company continues to execute…
Global health company The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization’s Board of Directors. His appointment is effective June 1, 2023. Since 2019, Dr. Philip Ozuah has served as the President and CEO…